XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Playback speed
10 seconds
Debates in CLL: The Case for Combination Therapy in 1L
23 views
February 16, 2024
Chapters
Combination vs Monotherapy in CLL Treatment
00:00
Survival Rates: Comparing Different CLL Therapies
01:59
MRD-Driven Therapy & High-Risk Patient Results
03:45
PFS Data for p53 & High-Risk CLL Subgroups
04:34
Maintaining MRD with Therapeutic Combinations
07:05
Evaluating Toxicity & Future of CLL Treatments
09:28
Comments 0
Login to view comments.
Click here to Login
Leukemia